Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Therapure, LFB in Development Services Contract | Contract Pharma

What are you searching for?

Sign in
Breaking News

Therapure, LFB in Development Services Contract

Therapure BioPharma, Inc. has been selected by LFB Biotechnologies, a subsidiary of LFB SA, for the development of a manufacturing method for a plasma therapeutic protein.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Therapure BioPharma, Inc. has been selected by LFB Biotechnologies, a subsidiary of LFB SA, for the development of a manufacturing method for a plasma therapeutic protein. Therapure will develop a manufacturing process for the large-scale production of a biologic for clinical trials. R&D teams from both companies will manage the project. The potential treatment is for a serious illness that currently has limited treatment options, according to a joint statement.

“We are pleased that LFB Biotechnologies, a major European player in the therapeutic protein field, has selected Therapure Biopharma for this important work,” said Thomas Wellner, president and chief executive officer of Therapure BioPharma. “Our development team has extensive knowledge in the area of plasma proteins purification and manufacturing methods and we have already achieved some key milestones in this project.”

“We have a strong expertise in the development and manufacture of plasma-derived medicinal products and an important R&D portfolio.  We have chosen to identify partners with complementary knowledge and the skills to help us to advance some of our products,” said Bernard Pelletier, strategic development program director, LFB Biotechnologies. “We have recognized the strong technical capabilities of Therapure Biopharma in this area and we are pleased with the progress of the project to date.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics